10.03.2005 19:45:00
|
Chattem, Inc. Schedules Release of First Quarter Fiscal 2005 Results a
Business Editors
CHATTANOOGA, Tenn.--(BUSINESS WIRE)--March 10, 2005--Chattem, Inc. (NASDAQ:CHTT) announced today that it will issue its first quarter fiscal 2005 earnings release on Wednesday, March 23, 2005, after the market closes. The Company will host a conference call at 8:30 am EST on Thursday, March 24, 2005. Chairman & CEO Zan Guerry, President & COO Alec Taylor and Vice President & CFO Rick Moss will participate in the call. The conference call and webcast details are shown below.
Chattem, Inc. is a leading marketer and manufacturer of a broad portfolio of branded OTC healthcare products, toiletries and dietary supplements. The Company's products target niche market segments and are among the market leaders in their respective categories across food, drug and mass merchandisers. The Company's portfolio of products includes well-recognized brands such as Icy Hot(R), Gold Bond(R), Selsun blue(R), pHisoderm(R), Garlique(R), Pamprin(R) and BullFrog(R). Chattem conducts a portion of its global business through subsidiaries in the United Kingdom, Ireland and Canada.
Statements in this press release which are not historical facts are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements involve risks, uncertainties and assumptions that could cause actual outcomes and results to differ materially from those expressed or projected.
CONFERENCE CALL AND WEBCAST INSTRUCTIONS
DIALING INSTRUCTIONS:
Date Time Dial-In Number ---- ---- -------------- Thursday, March 24, 2005 8:30 a.m. EST 800-901-5231
International Participants 617-786-2961
Passcode 28742112
For those persons unable to attend during the Conference Call, a digital replay will be available immediately following the call through Thursday, March 31st @ 11:59 p.m. by dialing the following number:
REPLAY ------ Telephone: 888-286-8010
International: 617-801-6888
Passcode: 17811158
WEBCAST INSTRUCTIONS:
Click On This Link Found At www.chattem.com and www.streetevents.com
Note: Webcast requires Windows Media Player to participate in conference call.
--30--SH/na*
CONTACT: Chattem, Inc., Chattanooga Company Contacts: Alec Taylor, 423-821-2037, ext. 3281 or Rick Moss, 423-821-2037, ext. 3278 or Investor Relations: Catherine Baker, 423-821-2037, ext. 3209
KEYWORD: TENNESSEE INDUSTRY KEYWORD: MEDICAL CONSUMER/HOUSEHOLD MANUFACTURING EARNINGS CONFERENCE CALLS SOURCE: Chattem, Inc.
Copyright Business Wire 2005

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Sanofi S.A.mehr Nachrichten
18.02.25 |
Sanofi- & Regeneron-Aktien uneins: Dupixent mit schnellerem Prüfverfahren in den USA (Dow Jones) | |
18.02.25 |
EURO STOXX 50-Papier Sanofi-Aktie: So viel Gewinn hätte ein Investment in Sanofi von vor 5 Jahren eingefahren (finanzen.at) | |
11.02.25 |
EURO STOXX 50-Titel Sanofi-Aktie: So viel Gewinn hätte ein Investment in Sanofi von vor 3 Jahren abgeworfen (finanzen.at) | |
04.02.25 |
EURO STOXX 50-Titel Sanofi-Aktie: So viel Gewinn hätte ein Sanofi-Investment von vor einem Jahr eingefahren (finanzen.at) | |
03.02.25 |
L'Oréal-Aktie schwächer: Rückverkauf von Sanofi-Aktien angekündigt (Dow Jones) | |
03.02.25 |
KORREKTUR: Pharmakonzern Sanofi erwirbt größeres Aktienpaket von L'Oreal (dpa-AFX) | |
03.02.25 |
Pharmakonzern Sanofi erwirbt größeres Aktienpaket von L'Oreal (dpa-AFX) | |
30.01.25 |
KORREKTUR: Sanofi kauft für 5 Mrd Euro Aktien zurück - Wachstum 2025 hoch einstellig (Dow Jones) |
Analysen zu Sanofi S.A.mehr Analysen
20.02.25 | Sanofi Outperform | Bernstein Research | |
14.02.25 | Sanofi Neutral | JP Morgan Chase & Co. | |
13.02.25 | Sanofi Buy | UBS AG | |
03.02.25 | Sanofi Buy | UBS AG | |
31.01.25 | Sanofi Kaufen | DZ BANK |
Aktien in diesem Artikel
Sanofi S.A. | 104,24 | 1,40% |
|
Indizes in diesem Artikel
NASDAQ Comp. | 19 004,82 | -1,46% |